logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
M

Masahito Nakano

kurume university
H指数:25
被引数:1,971

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Conversion Hepatectomy After New FP Therapy for Malignant Hepatocellular Neoplasm, Not Otherwise Specified: A Case Report

恶性肝细胞肿瘤（Not Otherwise Specified）经新FP疗法后行转化性肝切除术：一例病例报告

Hepatology Research
IF3.4
2026-02-240
PRE
Etsuko Moriyama; Hironori Koga; Takashi Niizeki; Hideki Iwamoto; Shigeo Shimose; Tomotake Shirono; Takahiko Tokushige; Masahito Nakano; Ryoko Kuromatsu; Toru Goto; Masaki Honda; Taizo Hibi; Yoshiki Mikami; Reiichiro Kondo; Jun Akiba; Takumi Kawaguchi
Meta-Analysis: Utilisation of Hepatocellular Carcinoma Surveillance

Meta-Analysis: 肝细胞癌筛查的应用

Alimentary Pharmacology & Therapeutics
IF6.7
2025-10-120
PRE
Nicole Shu Ying Tang; Shyna Gunalan; Christen En Ya Ong; Benjamin Koh; Ethan Kai Jun Tham; Ryan Yanzhe Lim; Darren Jun Hao Tan; Nicholas Syn; Cheng Han Ng; Mark Muthiah; Pojsakorn Danpanichkul; Karn Wijarnpreecha; Masahito Nakano; Asako Nogami; Atsushi Nakajima; Ming-Hua Zheng; Hirokazu Takahashi; Arndt Vogel; Mei Chin Lim; Daniel Q. Huang
Incidence of Hepatocellular Carcinoma in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Reconstructed Individual Patient Data Meta-Analysis

代谢功能障碍相关脂肪性肝病中肝细胞癌的发生率：一项重建的个体患者数据荟萃分析

Clinical Gastroenterology and Hepatology
IF12
2025-09-090
PRE
Ryan Yanzhe Lim; Faith Xin Ning Tan; Glenn Jun Kit Ho; Ethan Kai Jun Tham; Alfred Kow; Guoyue Lv; Zhong-Qi Fan; Nicholas Syn; Masahito Nakano; Wenhao Li; Karn Wijarnpreecha; Jörn M. Schattenberg; Vincent Chen; Ming-Hua Zheng; Pojsakorn Danpanichkul; Hirokazu Takahashi; Cheng Han Ng; Yoshio Sumida; Atsushi Nakajima; Mazen Noureddin; Mark D. Muthiah; Daniel Q. Huang
Comparison Analysis of Lenvatinib Plus Transcatheter Arterial Chemoembolization Versus Atezolizumab Plus Bevacizumab as First-Line Therapy for Intermediate-Stage Hepatocellular Carcinoma Beyond the Up-to-Seven Criteria

仑伐替尼联合经导管动脉化疗栓塞与阿替利珠单抗联合贝伐珠单抗作为超出“七限”标准的中间期肝细胞癌的一线治疗比较分析

Journal of Gastroenterology and Hepatology
IF3.4
2025-05-310
PRE
Takashi Niizeki; Seiichi Mawatari; Michihiko Shibata; Ryu Sasaki; Shinji Itoh; Satoshi Shakado; Rie Sugimoto; Yusuke Morita; Takuya Kuwashiro; Mizuki Endo; Masao Iwao; Yasuhide Motoyoshi; Masahito Nakano; Shigeo Shimose; Hirokazu Takahashi; Hiroshi Yatsuhashi; Fumihito Hirai; Tomoharu Yoshizumi; Hisamitsu Miyaaki; Takumi Kawaguchi; Akio Ido; Masaru Harada
Metabolic dysfunction-associated fatty liver disease is a ubiquitous latent cofactor in viral- and alcoholic-related hepatocellular carcinoma: Editorial on Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis

代谢功能障碍相关的脂肪肝是病毒和酒精相关的肝细胞癌中普遍存在的潜在辅因子: 关于代谢功能障碍相关的脂肪肝相关的肝细胞癌的全球患病率的编辑: 系统回顾和荟萃分析

CLINICAL AND MOLECULAR HEPATOLOGY
IF16.9
2024-10-012
OAAI
Nakamura, Toru; Nakano, Masahito; Tsutsumi, Tsubasa; Amano, Keisuke; Kawaguchi, Takumi
Tumor-derived insulin-like growth factor-binding protein-1 contributes to resistance of hepatocellular carcinoma to tyrosine kinase inhibitors
CANCER COMMUNICATIONS
IF24.9
2023-02-246
OAAI
Suzuki, Hiroyuki; Iwamoto, Hideki; Seki, Takahiro; Nakamura, Toru; Masuda, Atsutaka; Sakaue, Takahiko; Tanaka, Toshimitsu; Imamura, Yasuko; Niizeki, Takashi; Nakano, Masahito; Shimose, Shigeo; Shirono, Tomotake; Noda, Yu; Kamachi, Naoki; Sakai, Miwa; Morita, Kazutoyo; Nakayama, Masamichi; Yoshizumi, Tomoharu; Kuromatsu, Ryoko; Yano, Hirohisa; Cao, Yihai; Koga, Hironori; Torimura, Takuji
Significance of ramucirumab following atezolizumab plus bevacizumab therapy for hepatocellular carcinoma using real-world data

使用真实世界数据，阿特珠单抗联合贝伐单抗治疗肝细胞癌后雷莫昔单抗的意义

HEPATOLOGY RESEARCH
IF3.4
2022-11-167
PRE
Shimose, Shigeo; Sugimoto, Rie; Hiraoka, Atsushi; Tanaka, Masatoshi; Iwamoto, Hideki; Tanaka, Yuki; Tada, Fujimasa; Ohama, Hideko; Niizeki, Takashi; Shirono, Tomotake; Moriyama, Etsuko; Noda, Yu; Kamachi, Naoki; Nakano, Masahito; Kuromatsu, Ryoko; Koga, Hironori; Kawaguchi, Takumi
The beneficial impact of metabolic dysfunction-associated fatty liver disease on lenvatinib treatment in patients with non-viral hepatocellular carcinoma
HEPATOLOGY RESEARCH
IF3.4
2022-11-0622
PRE
Shimose, Shigeo; Hiraoka, Atsushi; Casadei-Gardini, Andrea; Tsutsumi, Tsubasa; Nakano, Dan; Iwamoto, Hideki; Tada, Fujimasa; Rimini, Margherita; Tanaka, Masatoshi; Torimura, Takuji; Suga, Hideya; Ohama, Hideko; Burgio, Valentina; Niizeki, Takashi; Moriyama, Etsuko; Suzuki, Hiroyuki; Shirono, Tomotake; Noda, Yu; Kamachi, Naoki; Nakano, Masahito; Kuromatsu, Ryoko; Koga, Hironori; Kawaguchi, Takumi
Deterioration of liver function and aging disturb sequential systemic therapy for unresectable hepatocellular carcinoma
SCIENTIFIC REPORTS
IF3.9
2022-10-118
OAAI
Shimose, Shigeo; Hiraoka, Atsushi; Tanaka, Masatoshi; Iwamoto, Hideki; Tanaka, Takaaki; Noguchi, Kazunori; Aino, Hajime; Yamaguchi, Taizo; Itano, Satoshi; Suga, Hideya; Niizeki, Takashi; Moriyama, Etsuko; Shirono, Tomotake; Noda, Yu; Kamachi, Naoki; Okamura, Shusuke; Nakano, Masahito; Kawaguchi, Takumi; Kuromatsu, Ryoko; Koga, Hironori; Torimura, Takuji

研究方向

暂未获取到该数据
T
Takumi Kawaguchi
H 指数:61论文数:514被引数:2.4万
T
Takuji Torimura
H 指数:58论文数:471被引数:1.3万
H
Hideki Iwamoto
H 指数:39论文数:338被引数:5,439
S
Shigeo Shimose
H 指数:28论文数:138被引数:2,238
T
Takashi Niizeki
H 指数:31论文数:153被引数:2,493
R
Ryoko Kuromatsu
H 指数:32论文数:163被引数:3,909
H
Hironori Koga
H 指数:47论文数:258被引数:8,689
T
Tomotake Shirono
H 指数:21论文数:79被引数:1,361
Y
Yu Noda
H 指数:17论文数:75被引数:926
N
Naoki Kamachi
H 指数:15论文数:45被引数:673